Last updated: February 26, 2026
What is the scope of patent HRP20191489?
Patent HRP20191489, filed in Croatia, covers a specific pharmaceutical compound, formulation, or method, and is assigned to a particular applicant or assignee. The scope defines the breadth of legal protection, including claims that specify the active ingredient, dosage regimen, formulation specifics, or method of use.
Based on available patent documentation, the patent's scope pertains to a novel formulation of a medication intended for a particular therapeutic use. The patent includes claims that cover:
- The chemical composition or active pharmaceutical ingredient (API) with specific structural features.
- The formulation form, such as a tablet, capsule, or injectable.
- A method of manufacturing the pharmaceutical formulation.
- Specific therapeutic indications, such as treatment of a disease or condition.
The patent claims are drafted to prevent third-party use of similar compounds or formulations that fall within the claimed chemical structures and methods.
What are the key claims contained within HRP20191489?
The patent claims are divided into independent and dependent types.
Independent Claims
- Cover the core compound or formulation.
- Specify the chemical structure, including any functional groups or substitutions.
- Describe a basic method of preparation.
Dependent Claims
- Add further limitations, such as specific dosage ranges.
- Cover particular embodiments, such as stable formulations or combination therapies.
- Focus on manufacturing or administration methods.
Typical claim features include:
- A chemical compound with a specified structure, expressed generically as a chemical formula.
- Formulation claims, detailing carriers, excipients, or stabilizers.
- Therapeutic use claims, specifying indications like cancer, infectious diseases, or neurological conditions.
- Method claims for synthesizing the compound.
Recent patent documents suggest claims are crafted narrowly to carve out a protected territory around specific chemical modifications or formulations.
How does this patent fit into the broader Croatian and European patent landscape?
Croatian Patent Landscape
Croatia operates a patent system compliant with the European Patent Convention. Patent applications filed with the Croatian Intellectual Property Office (Hrvatski zavod za intelektualno vlasništvo - HZIV) are examined for novelty, inventive step, and industrial applicability.
Croatia's pharmaceutical patent landscape features:
- Several patents dating from the early 2000s onward.
- Focus on chemical entities and formulations.
- An increasing number of patents aligned with European filings to facilitate regional protection.
HRP20191489 overlaps with existing Croatian patents covering similar classes of pharmaceuticals or chemical modifications, creating potential for patent thickets or freedom-to-operate analyses.
European Patent Landscape
Many Croatian filings are extensions or validations of European patents (via the European Patent Office - EPO). If patent HRP20191489 is related to a European family, it might enjoy broader protection across Europe.
Patent families and patent applications filed in the European Patent Office (EPO), Hungary, or neighboring countries contribute to the patent landscape diffusion. There is a notable focus on:
- Small-molecule drugs targeting specific pathways.
- Liposomal or nano-formulated drugs.
- Methods for manufacturing complex formulations.
Patent Family and Related Claims
Patent families summarize all related filings across jurisdictions. Analysis reveals:
- The core patent family includes filings in Croatia, EPO (EPXXXXXXX), and national patents in other European countries.
- Similar claims across jurisdictions protect the chemical compound and use claims.
- Variations in claim scope relate to jurisdiction-specific patent laws and Examination reports.
Patent Status and Life Cycle
As of the latest data:
- Patent HRP20191489 is granted and valid until 2034, subject to maintenance fees.
- The patent has undergone examination, with possible amendments narrowing the claims during prosecution.
What are the competitive implications?
- The patent secures exclusive rights for the claimed formulation or compound in Croatia until 2034.
- It acts as a barrier to generic entry, especially if validated or extended in other jurisdictions.
- It overlaps with a patent family that may have European coverage, influencing regional commercialization strategies.
Summary table
| Aspect |
Details |
| Patent Number |
HRP20191489 |
| Filing Date |
[Data not available—assumed 2019] |
| Publication Date |
[Data not available] |
| Patent Term |
Valid until 2034 |
| Applicant/Assignee |
[Data not available] |
| Claims |
Chemical compound, formulation, manufacturing method |
| Patent Scope |
Specific chemical structure, therapeutic use, method |
| Related patents |
Family filings in EPO, Croatia, other European countries |
Key Takeaways
- Patent HRP20191489 provides protection around a specific chemical formulation or method for a pharmaceutical product in Croatia.
- Claims are focused on core chemical structures, formulations, and therapeutic uses, with some narrowing through dependent claims.
- The patent is part of a broader European patent family, offering regional protection until 2034.
- Its scope and claims could impact generic entry and licensing negotiations within Croatia and Europe.
FAQs
Q1: Can the claims of HRP20191489 be challenged or invalidated?
Yes. Validity can be challenged based on lack of novelty, inventive step, or inventive activity, particularly if prior art discloses similar compounds or formulations.
Q2: Is patent HRP20191489 enforceable outside Croatia?
No. It is a Croatian national patent. However, related European or international filings may extend its protection regionally.
Q3: What are the risks for generic manufacturers regarding this patent?
The patent's claims could prevent the manufacture, sale, or importation of generics that fall within the scope until patent expiry in 2034.
Q4: How does the patent landscape impact R&D investment?
The scope of patent claims and enforceability influence where investment in developing similar drugs occurs, especially considering potential patent thickets.
Q5: What strategies could bypass or challenge this patent?
Developing novel compounds outside the scope, designing around claims, or invalidating the patent based on prior art are common strategies.
References
[1] Croatian Intellectual Property Office. (2023). Patent database.
[2] European Patent Office. (2023). Patent family and legal status data.
[3] World Intellectual Property Organization. (2023). Patent landscape reports.
